GlaxoSmithKline Stock News Today

<div class='circular--portrait' style='background:#754DEB;color: #F0FFF0;font-size:4em;padding-top: 25px;;'>GP</div>
GSK -- USA Stock  

Fiscal Quarter End: 30th of June 2020  

GlaxoSmithKline Stock News module provides quick insight into current market opportunities from investing in GlaxoSmithKline PLC. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use GlaxoSmithKline PLC stock news signals to limit their universe of possible portfolio assets and to time the market correctly. Please check GlaxoSmithKline PLC Hype Analysis, GlaxoSmithKline PLC Correlation and GlaxoSmithKline PLC Performance.

Search Today's Stock News

 
Refresh
GlaxoSmithKline PLC stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of GlaxoSmithKline daily returns and investor perception about the current pice of GlaxoSmithKline PLC as well as its diversification or hedging effects on your existing portfolios.
  
2 days ago at moneymorning.com         
How Is the Economy Doing Short- and Long-Term Economic Impacts of COVID-19 - Money Morning
M
How Is the Economy Doing Short- and Long-Term Economic Impacts of COVID-19 Money Morning
  
  
over a week ago at www.bloomberg.com         
Glaxo to Make 1 Billion Doses of Pandemic Vaccine Booster - Bloomberg
bloomberg News
Glaxo to Make 1 Billion Doses of Pandemic Vaccine Booster Bloomberg
  
  
over two weeks ago at www.nasdaq.com         
GSK ties up with gene editing start-up Mammoth for COVID-19 test - Nasdaq
nasdaq News
GSK ties up with gene editing start-up Mammoth for COVID-19 test Nasdaq
  
  
over two weeks ago at www.benzinga.com         
Moncef Slaoui To Divest Moderna Stake As He Joins White House Vaccine Accelerator - Benzinga
benzinga news
Moncef Slaoui To Divest Moderna Stake As He Joins White House Vaccine Accelerator Benzinga
  
  
over three weeks ago at 247wallst.com         
Huge Sales Growth Brightens Future for Amarin Stock - 247 Wall St.
2
Huge Sales Growth Brightens Future for Amarin Stock 247 Wall St.
  
  
over three weeks ago at www.nasdaq.com         
3 Things to Know About Stablecoins - Nasdaq
nasdaq News
3 Things to Know About Stablecoins Nasdaq
  
  
over three weeks ago at www.gurufocus.com         
May 11, 2020 - Arjuna Capital Buys Bank of New York Mellon Corp, Biogen Inc, American Water Works Co...
G
May 11, 2020 - Arjuna Capital Buys Bank of New York Mellon Corp, Biogen Inc, American Water Works Co Inc, Sells Johnson Johnson, Sonoco Products Co, The Travelers Inc GuruFocus.com
  
  
over a month ago at www.marketwatch.com         
Pound slumps after construction sector sees worst decline on record - MarketWatch
marketwatch News
Pound slumps after construction sector sees worst decline on record MarketWatch
  
  
over a month ago at simplywall.st         
Earnings Beat GlaxoSmithKline plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their...
Simply Wall St News at Macroaxis
Earnings Beat GlaxoSmithKline plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models Simply Wall St
  
  
over a month ago at www.nasdaq.com         
GlaxoSmithKline plc Q1 2020 Earnings Call Transcript - Nasdaq
nasdaq News
GlaxoSmithKline plc Q1 2020 Earnings Call Transcript Nasdaq
  
  
over a month ago at finance.yahoo.com         
Move Over, FAANGs. Goldman Unveils Europes GRANOLAS Stocks - Yahoo Finance
Yahoo News
Move Over, FAANGs. Goldman Unveils Europes GRANOLAS Stocks Yahoo Finance
  
  
over a month ago at www.bloomberg.com         
Sanofi Says Coronavirus Vaccine Question Isnt When, But How Much - Bloomberg
bloomberg News
Sanofi Says Coronavirus Vaccine Question Isnt When, But How Much Bloomberg
  
  
over a month ago at newswelcome.com         
Price Target Recommendation GlaxoSmithKline plc to knock at 48.25 in coming one year period - News W...
WN
Price Target Recommendation GlaxoSmithKline plc to knock at 48.25 in coming one year period News Welcome
  
  
over a month ago at finance.yahoo.com         
Vaccines Market Landscape to 2027 by Type, Technology, Disease Indication, Route of Administration, ...
Yahoo News
Vaccines Market Landscape to 2027 by Type, Technology, Disease Indication, Route of Administration, Distribution Channel, End-user and Geography Yahoo Finance
  
  
over a month ago at finance.yahoo.com         
SanofiLuminostics to Make Self-Testing Solution for Coronavirus - Yahoo Finance
Yahoo News
SanofiLuminostics to Make Self-Testing Solution for Coronavirus Yahoo Finance
  

Investors are also looking into

GlaxoSmithKline PLC Performance against DOW

 Price Growth (%)  
      Timeline 
1
Should You Buy GlaxoSmithKline plc Stock Friday - InvestorsO...03/13/2020
2
Other03/18/2020
3
COVID-19 Diagnostic Tests - Nasdaq03/20/2020
4
Other03/24/2020
5
Interested In Stock GlaxoSmithKline plc, - NasdaqNewsUpdates03/30/2020
6
Other04/01/2020
7
Other04/06/2020
8
Stock Highlights GlaxoSmithKline plc, - NasdaqNewsUpdates04/09/2020
9
Other04/14/2020
10
Apr 15, 2020 - T Rowe Price Equity Income Fund Buys AbbVie I...04/15/2020
11
Other04/16/2020
12
Vaccines Market Landscape to 2027 by Type, Technology, Disea...04/22/2020
13
Move Over, FAANGs. Goldman Unveils Europes GRANOLAS Stocks -...04/28/2020
14
Other04/29/2020
15
Other04/30/2020
16
Other05/01/2020
17
Other05/04/2020
18
Pound slumps after construction sector sees worst decline on...05/06/2020
19
Other05/07/2020
20
Other05/11/2020
21
Other05/12/2020
22
Huge Sales Growth Brightens Future for Amarin Stock - 247 Wa...05/13/2020
23
Other05/18/2020
24
Other05/19/2020
25
Unclassified Event05/26/2020
26
How Is the Economy Doing Short- and Long-Term Economic Impac...06/04/2020
Please check GlaxoSmithKline PLC Hype Analysis, GlaxoSmithKline PLC Correlation and GlaxoSmithKline PLC Performance. Please also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page